Meta becomes the latest big tech company turning to nuclear power for its AI needs
This June 2, 2016 file photo shows the Clinton Clean Energy Center in Clinton, Ill. (John Dixon/The News-Gazette via AP)
WASHINGTON — Meta has cut a 20-year deal to secure nuclear power to help meet surging demand for artificial intelligence and other computing needs at Facebook's parent company.
The investment with Meta will also expand the output of a Constellation Energy Illinois nuclear plant.
The agreement announced Tuesday is just the latest in a string of tech-nuclear partnerships as the use of AI expands. Financial details of the agreement were not disclosed.
Constellation's Clinton Clean Energy Center was actually slated to close in 2017 after years of financial losses but was saved by legislation in Illinois establishing a zero-emission credit program to support the plant into 2027. The Meta-Constellation deal takes effect in June of 2027, when the state's taxpayer funded zero-emission credit program expires.
With the arrival of Meta, Clinton's clean energy output will expand by 30 megawatts, preserve 1,100 local jobs and bring in $13.5 million in annual tax revenue, according to the companies.
'Securing clean, reliable energy is necessary to continue advancing our AI ambitions,' said Urvi Parekh, Meta's head of global energy.
Constellation, the owner of the shuttered Three Mile Island nuclear power plant, said in September that it planned to restart the reactor so tech giant Microsoft could secure power to supply its data centers. Three Mile Island, located on the Susquehanna River just outside Harrisburg, Pennsylvania, was the site of the nation's worst commercial nuclear power accident in 1979.
Also last fall, Amazon said it was investing in small nuclear reactors, two days after a similar announcement by Google. Additionally, Google announced last month that it was investing in three advanced nuclear energy projects with Elementl Power.
U.S. states have been positioning themselves to meet the tech industry's power needs as policymakers consider expanding subsidies and gutting regulatory obstacles.
Last year, 25 states passed legislation to support advanced nuclear energy, and lawmakers this year have introduced over 200 bills supportive of nuclear energy, according to the trade association Nuclear Energy Institute.
Advanced reactor designs from competing firms are filling up the federal government's regulatory pipeline as the industry touts them as a reliable, climate-friendly way to meet electricity demands from tech giants desperate to power their fast-growing artificial intelligence platforms.
Amazon, Google and Microsoft also have been investing in solar and wind technologies, which make electricity without producing greenhouse gas emissions.
Matt Ott, The Associated Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
37 minutes ago
- Globe and Mail
Stock Market News for Jun 11, 2025
U.S. stock markets closed higher on Tuesday as market participants awaited U.S.-China trade deals. A couple of major AI related news also boosted investors sentiment in risky assets like equities. All three major stock indexes ended in positive territory. How Did The Benchmarks Perform? The Dow Jones Industrial Average (DJI) advanced 0.3% or 105.11 points to close at 42,866.87. Notably, 21 components of the 30-stock index ended in positive territory and 9 finished in negative zone. The tech-heavy Nasdaq Composite finished at 19,714.99, rising 0.6% or 123.75 points due to strong performance of technology bigwigs. The S&P 500 increased 0.6% to finish at 6,038.81. Wall Street's most observed benchmark is currently less than 2% away from its all-time high. 10 out of 11 broad sectors of the broad-market index ended in positive territory while one in negative zone. The Consumer Discretionary Select Sector SPDR (XLY), the Communication Services Select Sector SPDR (XLC), the Energy Select Sector SPDR (XLE) and the Health Care Select Sector SPDR (XLV) climbed 1.2%, 1.3%, 1.8% and 1.1%, respectively. The fear-gauge CBOE Volatility Index (VIX) was down 1.2% to 16.95. A total of 18.5 billion shares were traded on Tuesday, higher than the last 20-session average of 17.9 billion. The S&P 500 recorded 12 new 52-week highs and 2 new 52-week lows. The Nasdaq registered 75 new 52-week highs and 45 new 52-week lows. Investors Hope U.S-China Trade Deals The trade and tariff related negotiations between the United States and China reinitiated in London on last Monday. U.S. Treasury Secretary Scott Bessent and two other top level Trump administration officials has been negotiating with their Chinese counterparts in order to negotiate tariffs and trade related disputes between the two largest trading partners of the world. Aside from Bessent, other two U.S. delegators will be Commerce Secretary Howard Lutnick and U.S. Trade Representative Jamieson Greer. Chinese Vice Premier He Lifeng will hold the first round of trade and economic talks with the U.S. Talks will continue on Tuesday. National Economic Council Director Kevin Hassett said Monday that the U.S. was seeking confirmation that China would restore critical mineral exports. Beijing protested against the U.S. Commerce Department's warnings to U.S. chipset manufacturers against using Chinese semiconductors. On Tuesday, Lutnick said, 'I think the talks are going really, really well. We're very much spending time and effort and energy - everybody's got their head down working closely.' Lutnick further said that talks may continue Wednesday morning if required. On May 12, the United States and China have decided to for a 90-day pause of tariff implementations. The two countries agreed in a discussion in Switzerland to reach a temporary agreement that 'reciprocal' tariffs between both countries will be cut from 125% to 10%. United States' 20% tariffs on Chinese imports relating to fentanyl will remain intact, meaning total tariffs on China will be 30%. Developments on AI Front Meta Platforms Inc. META is finalizing a deal to invest $14 billion to artificial intelligence (AI) startup Scale AI and will pursue its CEO Alexandr Wang to join META. Mark Zuckerberg is willing to utilize Wang's reputation to successfully build business based on AI's technical complexities. Open AI entered a deal with Google Cloud of Alphabet Inc. GOOGL in order to meet its growing needs for computing capacity. The deal between two AI ecosystem competitors has surprised many financial experts. Stock prices of Meta Platforms and Alphabet rose 1.4% and 1.2%, respectively. Both stocks currently carry a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Alphabet Inc. (GOOGL): Free Stock Analysis Report Meta Platforms, Inc. (META): Free Stock Analysis Report
Globe and Mail
42 minutes ago
- Globe and Mail
3 Growth Stocks That Could Skyrocket in 2025 and Beyond
After a choppy start to the year, the market appears to be finding its footing. With investor sentiment stabilizing, now looks like a good time to scoop up some high-quality growth names with strong upside potential in 2025 and beyond. Here are three growth stocks that could gain some serious momentum in the months and years ahead. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Amazon Despite being a $2 trillion-plus market-cap stock, Amazon (NASDAQ: AMZN) is still a compelling growth stock. While best known for its e-commerce business, Amazon is also a leader in cloud computing, digital advertising, and, increasingly, artificial intelligence (AI). Despite a recent rally off its lows, the stock still trades at one of the most attractive valuations in its history. Amazon's biggest growth driver today is AI, which it is using across its businesses to improve efficiency and help drive growth. In its e-commerce segment, it is using AI to help optimize delivery routes, automate warehouse operations, and even reduce returns by identifying damaged items before they ship. This is driving strong operating leverage, with North America operating income climbing 16% in Q1 on just 8% revenue growth. Meanwhile, it is also using AI to improve how third-party sellers create product listings. It is also helping these merchants to better target consumers through its fast-growing sponsored ads platform. Meanwhile, its cloud computing business, Amazon Web Services (AWS), remains its most profitable and fastest-growing segment. Customers are building AI models using AWS tools like Bedrock and SageMaker, which are then run on its infrastructure. Amazon has also built its own custom AI chips to make its infrastructure more cost-efficient and give it a competitive edge. Risks remain, including tariff headwinds and the chance that Amazon could overbuild its AI infrastructure. That said, the company has a long track record of investing aggressively in major growth trends and coming out the other side a stronger company. As such, Amazon still looks like a great growth stock to own. Toast If you've recently visited a local restaurant, there is a good chance you've come across Toast's (NYSE: TOST) point-of-sale systems. However, the company has expanded well beyond payment processing, and today, it offers an all-in-one platform that helps restaurants run their businesses more efficiently. What sets Toast apart is its consistent product innovation. The company has rolled out features like delivery integration, mobile ordering, and digital invoicing. It's also started to integrate AI into its platform, piloting tools like "sous chef" and "ToastIQ" to help restaurants improve operations, gain business insights, and improve the customer experience. These innovations are all meant to help drive restaurant sales, which in turn benefits Toast since it gets a cut of customer sales through its payment processing offering. Toast is seeing strong traction, adding new customers. In Q1 2025, the company added over 6,000 net new restaurant locations, bringing its total to 140,000, up 25% year over year. Importantly, the company is starting to make inroads both in the enterprise space and internationally. It also landed large enterprise deals with Applebee's and Topgolf, and it is showing solid progress in its early international expansion efforts. As a result, Toast raised its full-year guidance and now expects fintech and subscription gross profit to increase by about 26%. While the economy and competition are risks, with a long growth runway ahead, Toast looks like a stock with strong upside still ahead. E.l.f. Beauty After hitting a rough patch earlier this year, e.l.f. Beauty's (NYSE: ELF) fortunes are looking up after it recently announced a $1 billion acquisition of Hailey Bieber's skincare and cosmetics brand Rhode. The deal should set the company up for its next stage of strong growth. Under the leadership of Bieber, Rhode became a breakout beauty brand, generating over $200 million in sales in just two years. Impressively, this was done with little paid advertising and a small product lineup. The brand is particularly popular among Gen Z consumers. With Bieber staying on as chief creative officer and the likelihood of an expanded product lineup, Rhode should be a strong growth engine for e.l.f. Beauty in the coming years. What makes this deal even more compelling, though, are the potential market synergies. While e.l.f. Beauty has been taking market share in the mass-market cosmetics space, Rhode is a more premium brand that is strong in both cosmetics and skincare. After primarily being an online-only brand, Rhode was already set to roll out to Sephora later this year. However, with a strong presence at major retailers like Target and Ulta Beauty, e.l.f. Beauty should be able to accelerate Rhode's retail expansion even more, given its strong distribution network. Even before the deal, e.l.f. Beauty was expanding globally and gaining share in both skincare and cosmetics. While there are tariff and acquisition-integration risks, Rhode should be a strong growth driver that can help power e.l.f. Beauty's stock this year and beyond. Should you invest $1,000 in Amazon right now? Before you buy stock in Amazon, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amazon wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,341!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $874,192!* Now, it's worth noting Stock Advisor 's total average return is999% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Geoffrey Seiler has positions in Toast and e.l.f. Beauty. The Motley Fool has positions in and recommends Amazon, Target, Toast, Ulta Beauty, and e.l.f. Beauty. The Motley Fool recommends Topgolf Callaway Brands. The Motley Fool has a disclosure policy.
Globe and Mail
an hour ago
- Globe and Mail
Should You Buy Eli Lilly Stock Before June 22?
(NYSE: LLY) stock hasn't been doing too well this year, but that could change later this month. A couple of key events are on the horizon this month during which the company will release new data from studies relating to multiple GLP-1 drugs. They can give investors insights into how well the drugs are doing, and whether approvals for new drugs and indications could be forthcoming in the near future. If Eli Lilly presents strong data, the stock could be set to rally and potentially be on a path to reaching new highs. Should you invest in this top healthcare company before June 22? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Eli Lilly to present data on multiple drugs later this month The American Diabetes Association (ADA) is hosting its 85th Scientific Sessions event in Chicago later this month, from June 20 to 23. Eli Lilly will report on data from studies related to multiple GLP-1 drugs, including tirzepatide (already approved for weight loss and diabetes under the Zepbound and Mounjaro brands), orforglipron (its oral weight-loss medication), and retatrutide -- one of the most promising GLP-1 treatments in the company's pipeline. On June 22, Eli Lilly will also be hosting an investor event which will go over key presentations from the ADA Scientific Sessions. For investors, there will be a lot of important data to unpack from all this. Encouraging data from key drugs could help lift shares of the company, as it may give investors reason to be bullish on further drug approvals, which would lead to stronger growth prospects for Eli Lilly and greater upside for the stock. The stock has struggled this year As of the end of last week, shares of Eli Lilly were flat since the start of 2025. There hasn't been a catalyst to send the stock soaring. While it has reached highs of more than $900 this year, fears of healthcare reform and a slowdown in the economy appear to be weighing on its valuation. Plus, with the stock trading at more than 60 times its trailing earnings, there can't be any hiccups along the way for Eli Lilly. At that high of a multiple, investors are going to be demanding near perfection from the business. However, Eli Lilly has been performing well. In the trailing 12 months, it has generated revenue of more than $49 billion, and its profits on that have totaled $11.1 billion. Just a few years ago, in 2022, this was a business that was only bringing in less than $29 billion in revenue. Its profit that year was much more modest at $6.2 billion. The growth in its new GLP-1 drugs has transformed the business in a strong, positive way. And that's why strong and impressive data from the upcoming ADA event could be what gets the stock rallying again. Should you buy Eli Lilly before June 22? Eli Lilly is a strong and robust business, with some promising growth prospects on the horizon. This is a stock I firmly believe can reach a $1 trillion valuation within the next few years, given just how much growth it may achieve. And if that's the case, its upside could be more than 45% from where it is today. While its year-to-date returns look unimpressive, this is a stock that has a lot more room to rise higher. Although Eli Lilly may not be the cheapest stock to own, a premium looks justifiable when factoring in the company's recent results and future growth opportunities. Buying it before the upcoming ADA event, which may light a fire under its valuation, could be a great move for investors in the long run. Should you invest $1,000 in Eli Lilly right now? Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,341!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $874,192!* Now, it's worth noting Stock Advisor 's total average return is999% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
